Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: A new vista for the treatment of comorbid alcohol and nicotine dependence?

Addictive Behaviors

Volumn 29, Issue 7, 2004, Pages 1465-1479

  Johnson, Bankole A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

amino butyric acid (GABA); Alcohol; Dopamine; Human; Nicotine; Topiramate

Indexed keywords

ALCOHOL; DOPAMINE; NICOTINE; TOPIRAMATE;

ALCOHOL CONSUMPTION; ALCOHOLISM; BRAIN CORTEX; COMORBIDITY; CONFERENCE PAPER; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; HUMAN; LIMBIC CORTEX; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROMODULATION; SMOKING; SMOKING CESSATION;

ALCOHOLISM; ANTICONVULSANTS; BRAIN; ETHANOL; FRUCTOSE; HUMANS; NICOTINE; TOBACCO USE DISORDER;

EID: 4444337987     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.06.014     Document Type: Conference Paper

References (98)

1. B. Abou-Khalil Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group Epilepsia 41 Suppl. 1 2000 S72 S76
2. N. Ait-Daoud, M.A. Javors, C.C. DiClemente, C.L. Bowden, N. Rosenthal, J.D. Roache, F.Z. Akhtar, J.Z. Ma, and B.A. Johnson Topiramate as an agent for smoking cessation? New Research Poster presented at the American Psychiatric Association Annual Meeting, New York 2004
3. E.X. Albuquerque, M. Alkondon, E.F. Pereira, N.G. Castro, A. Schrattenholz, C.T. Barbosa, R. Bonfante-Cabarcas, Y. Aracava, H.M. Eisenberg, and A. Maelicke Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function The Journal of Pharmacology and Experimental Therapeutics 280 1997 1117 1136
4. M. Angehagen, E. Ben-Menachem, L. Ronnback, and E. Hansson Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures Epilepsy Research 54 2003 63 71
5. J. Ayers, C.F. Ruff, and D.I. Templer Alcoholism, cigarette smoking, coffee drinking and extraversion Journal of Studies on Alcohol 37 1976 983 985
6. P. Batel, F. Pessione, C. Maitre, and B. Rueff Relationship between alcohol and tobacco dependencies among alcoholics who smoke Addiction 90 1995 977 980
7. N.L. Benowitz The use of biologic fluid samples in assessing tobacco smoke consumption NIDA Research Monograph 48 1983 6 26
8. B. Ben-Zeev, N. Watemberg, A. Augarten, N. Brand, Y. Yahav, O. Efrati, L. Topper, and I. Blatt Oligohydrosis and hyperthermia: Pilot study of a novel topiramate adverse effect Journal of Child Neurology 18 2003 254 257
9. M. Bialer, S.I. Johannessen, H.J. Kupferberg, R.H. Levy, P. Loiseau, and E. Perucca Progress report on new antiepileptic drugs: A summary of the fourth Eilat conference (EILAT IV) Epilepsy Research 34 1999 1 41
10. T.H. Bien, and R. Burge Smoking and drinking: A review of the literature International Journal of the Addictions 25 1990 1429 1454
11. V. Biton, K.R. Edwards, G.D. Montouris, J.C. Sackellares, C.L. Harden, M. Kamin Topiramate TPS-TR Study Group Topiramate titration and tolerability The Annals of Pharmacotherapy 35 2001 173 179
12. O. Blomqvist, M. Ericson, J.A. Engel, and B. Soderpalm Accumbal dopamine overflow after ethanol: Localization of the antagonizing effect of mecamylamine European Journal of Pharmacology 334 1997 149 156
13. O. Blomqvist, C.A. Hernandez-Avila, J. Van Kirk, J.E. Rose, and H.R. Kranzler Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol Alcoholism, Clinical and Experimental Research 26 2002 326 331
14. J.K. Bobo, L.D. Gilchrist, R.F. Schilling II, B. Noach, and S.P. Schinke Cigarette smoking cessation attempts by recovering alcoholics Addictive Behaviors 12 1987 209 215
15. J.K. Bobo, R.F. Schilling, L.D. Gilchrist, and S.P. Schinke The double triumph: Sustained sobriety and successful cigarette smoking cessation Journal of Substance Abuse Treatment 3 1986 21 25
16. M.J. Bohn, B.A. Barton, and K.E. Barron Psychometric properties and validity of the obsessive-compulsive drinking scale Alcoholism, Clinical and Experimental Research 20 1996 817 823
17. B. Borrelli, and R. Mermelstein The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program Addictive Behaviors 23 1998 609 622
18. C.R. Breese, R. Freedman, and S.S. Leonard Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers Brain Research 674 1995 82 90
19. T.A. Burling, G.D. Marshall, and A.L. Seidner Smoking cessation for substance abuse inpatients Journal of Substance Abuse 3 1991 269 276
20. T.A. Burling, P.M. Reilly, J.O. Moltzen, and D.C. Ziff Self-efficacy and relapse among inpatient drug and alcohol abusers: A predictor of outcome Journal of Studies on Alcohol 50 1989 354 360
21. T.A. Burling, and D.C. Ziff Tobacco smoking: A comparison between alcohol and drug abuse inpatients Addictive Behaviors 13 1988 185 190
22. Centers for Disease Control and Prevention Cigarette Smoking Among Adults - United States, 1993 MMWR, Morbidity and Mortality Weekly Report 43 1994 925 930
23. J.P. Changeux, D. Bertrand, P.J. Corringer, S. Dehaene, S. Edelstein, C. Lena, N. Le Novere, L. Marubio, M. Picciotto, and M. Zoli Brain nicotinic receptors: Structure and regulation, role in learning and reinforcement Brain Research. Brain Research Reviews 26 1998 198 216
24. P.M. Cinciripini Current trends in smoking cessation research: Psychological therapy, nicotine replacement and changes in smoking behavior Cancer Bulletin 47 1995 259 263
25. S. Cohen, E. Lichtenstein, J.O. Prochaska, J.S. Rossi, E.R. Gritz, C.R. Carr, C.T. Orleans, V.J. Schoenbach, L. Biener, D. Abrams, C. DiClemente, S. Curry, G.A. Marlatt, K.M. Cummings, S.L. Emont, G. Giovino, and D. Ossip-Klein Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves The American Psychologist 44 1989 1355 1365
26. A.C. Collins Interactions of ethanol and nicotine at the receptor level Recent Developments in Alcoholism 8 1990 221 231
27. S.J. Czuczwar, and P.N. Patsalos The new generation of GABA enhancers: Potential in the treatment of epilepsy CNS Drugs 15 2001 339 350
28. J.R. DiFranza, and M.P. Guerrera Alcoholism and smoking Journal of Studies on Alcohol 51 1990 130 135
29. P.R. Dodd, A.M. Beckmann, M.S. Davidson, and P.A. Wilce Glutamate-mediated transmission, alcohol, and alcoholism Neurochemistry International 37 2000 509 533
30. S.J. Dodgson, R.P. Shank, and B.E. Maryanoff Topiramate as an inhibitor of carbonic anhydrase isoenzymes Epilepsia 41 Suppl. 1 2000 S35 S39
31. W.E. Dodson, M. Kamin, L. Kraut, W.H. Olson, and S.C. Wu Topiramate titration to response: Analysis of individualized therapy study (TRAITS) The Annals of Pharmacotherapy 37 2003 615 620
32. D.R. Doose, K.A. Kohl, D. Desai-Krieger, J. Natarajan, and D.P. van Kammen No significant effect of topiramate on lithium serum concentration Poster presented at the World Congress of Psychiatry (WPA), Hamburg, Germany 1999
33. K.F. Dreher, and J.G. Fraser Smoking habits of alcoholic outpatients: I International Journal of the Addictions 2 1967 259 270
34. H.L. Edmonds Jr., Y.D. Jiang, P.Y. Zhang, and R. Shank Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration Life Sciences 69 2001 2265 2277
35. M.C. Fiore, S.L. Kenford, D.E. Jorenby, D.W. Wetter, S.S. Smith, and T.B. Baker Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments Chest 105 1994 524 533
36. W.R. Garnett Clinical pharmacology of topiramate: A review Epilepsia 41 Suppl. 1 2000 S61 S65
37. J.W. Gibbs, S. Sombati, R.J. DeLorenzo, and D.A. Coulter Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons Epilepsia 41 Suppl. 1 2000 S10 S16
38. R.E. Glasgow, L.A. Strycker, E.G. Eakin, S.M. Boles, and E.P. Whitlock Concern about weight gain associated with quitting smoking: Prevalence and association with outcome in a sample of young female smokers Journal of Consulting and Clinical Psychology 67 1999 1009 1011
39. D.S. Gryder, and M.A. Rogawski Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons The Journal of Neuroscience 23 2003 7069 7074
40. S.E. Hemby Neurobiology of alcoholism B.A. Johnson P. Ruiz M. Galanter Handbook of clinical alcoholism treatment 2003 Lippincott Williams and Wilkins Baltimore, MD 10 18
41. S.E. Hemby, B.A. Johnson, and S.I. Dworkin Neurobiological basis of drug reinforcement B.A. Johnson J.D. Roache Drug addiction and its treatment: Nexus of neuroscience and behavior 1997 Lippincott-Raven Philadelphia 137 169
42. A.I. Herrero, N. Del Olmo, J.R. Gonzalez-Escalada, and J.M. Solis Two new actions of topiramate: Inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance Neuropharmacology 42 2002 210 220
43. J.R. Hughes Treatment of smoking cessation in smokers with past alcohol/drug problems Journal of Substance Abuse Treatment 10 1993 181 187
44. R.D. Hurt, K.M. Eberman, I.T. Croghan, K.P. Offord, L.J. Davis Jr., R.M. Morse, M.A. Palmen, and B.K. Bruce Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial Alcoholism, Clinical and Experimental Research 18 1994 867 872
45. R.W. Jeffery, D.J. Hennrikus, H.A. Lando, D.M. Murray, and J.W. Liu Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation Health Psychology 19 2000 242 246
46. Johnson & Johnson Pharmaceutical Research & Development Investigator's Brochure: RWJ-17021-000 (Topiramate) 8th ed. 2003, July Ortho-McNeil Pharmaceutical, Inc. Raritan, NJ
47. B.A. Johnson Progress in the development of topiramate for treating alcohol dependence: From a hypothesis to a proof-of-concept study Alcoholism, Clinical and Experimental Research 28 2004 (in press)
48. B.A. Johnson, N. Ait-Daoud, C.L. Bowden, C.C. DiClemente, J.D. Roache, K. Lawson, M.A. Javors, and J.Z. Ma Oral topiramate for treatment of alcohol dependence: A randomised controlled trial Lancet 361 2003 1677 1685
49. S.H. Khan, S.L. Wright, A. Banigesh, H. Miyashita, K. Todd, S.J. Hemmings, T. Wishart, and A. Shuaib Antiischemic effects of topiramate in a transient global forebrain ischemia model: A neurochemical, histological, and behavioral evaluation Neurochemical Research 28 2003 1235 1239
50. S. Koh, and F.E. Jensen Topiramate blocks perinatal hypoxia-induced seizures in rat pups Annals of Neurology 50 2001 366 372
51. R.R. Kohl, J.S. Katner, E. Chernet, and W.J. McBride Ethanol and negative feedback regulation of mesolimbic dopamine release in rats Psychopharmacology 139 1998 79 85
52. L.T. Kozlowski, L.C. Jelinek, and M.A. Pope Cigarette smoking among alcohol abusers: A continuing and neglected problem Canadian Journal of Public Health 77 1986 205 207
53. L.T. Kozlowski, D.A. Wilkinson, W. Skinner, C. Kent, T. Franklin, and M. Pope Comparing tobacco cigarette dependence with other drug dependencies. Greater or equal 'difficulty quitting' and 'urges to use,' but less 'pleasure' from cigarettes JAMA, The Journal of the American Medical Association 261 1989 898 901
54. C. Ksir, R. Hakan, D.P. Hall Jr., and K.J. Kellar Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors Neuropharmacology 24 1985 527 531
55. R.L. Kuo, M.E. Moran, D.H. Kim, H.M. Abrahams, M.D. White, and J.E. Lingeman Topiramate-induced nephrolithiasis Journal of Endourology 16 2002 229 231
56. A.D. Lê Effects of nicotine on alcohol consumption Alcoholism, Clinical and Experimental Research 26 2002 1915 1916
57. A.D. Lê, W.A. Corrigall, S. Harding, J. Watchus, W. Juzytsch, and T.K. Li Involvement of nicotinic receptors in alcohol self-administration Alcoholism, Clinical and Experimental Research 24 2000 155 163
58. J. Littleton, and H. Little Interactions between alcohol and nicotine dependence: A summary of potential mechanisms and implications for treatment Alcoholism, Clinical and Experimental Research 26 2002 1922 1924
59. S.L. McElroy, L.M. Arnold, N.A. Shapira, P.E. Keck Jr., N.R. Rosenthal, M.R. Karim, M. Kamin, and J.I. Hudson Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial The American Journal of Psychiatry 160 2003 255 261
60. A.W. Meyers, R.C. Klesges, S.E. Winders, K.D. Ward, B.A. Peterson, and L.H. Eck Are weight concerns predictive of smoking cessation? A prospective analysis Journal of Consulting and Clinical Psychology 65 1997 448 452
61. N.S. Miller, and M.S. Gold Comorbid cigarette and alcohol addiction: Epidemiology and treatment Journal of Addictive Diseases 17 1998 55 66
62. W.R. Miller, K.E. Hedrick, and C.A. Taylor Addictive behaviors and life problems before and after behavioral treatment of problem drinkers Addictive Behaviors 8 1983 403 412
63. D.H. Moak, R.F. Anton, and P.K. Latham Further validation of the Obsessive-Compulsive Drinking Scale (OCDS): Relationship to alcoholism severity The American Journal on Addictions 7 1998 14 23
64. B. Moghaddam, and M.L. Bolinao Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release Synapse 18 1994 337 342
65. A.H. Mokdad, J.S. Marks, D.F. Stroup, and J.L. Gerberding Actual causes of death in the United States, 2000 JAMA, The Journal of the American Medical Association 291 2004 1238 1245
66. G.D. Montouris, V. Biton, and W.E. Rosenfeld Nonfocal generalized tonic-clonic seizures: Response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group Epilepsia 41 Suppl. 1 2000 S77 S81
67. R.P. Murray, J.A. Istvan, H.T. Voelker, M.A. Rigdon, and M.D. Wallace Level of involvement with alcohol and success at smoking cessation in the lung health study Journal of Studies on Alcohol 56 1995 74 82
68. T. Narahashi, B. Söderpalm, M. Ericson, P. Olausson, J.A. Engel, X. Zhang, A. Nordberg, W. Marszalec, G.L. Aistrup, L.G. Schmidt, U. Kalouti, M. Smolka, and L. Hedlund Mechanisms of alcohol-nicotine interactions: Alcoholics versus smokers Alcoholism, Clinical and Experimental Research 25 5 Suppl. ISBRA 2001 152S 156S
69. M. Niebauer, and M. Gruenthal Topiramate reduces neuronal injury after experimental status epilepticus Brain Research 837 1999 263 269
70. D.J. Ossip-Klein, G. Bigelow, S.R. Parker, S. Curry, S. Hall, and S. Kirkland Classification and assessment of smoking behavior Health Psychology 5 Suppl. 1986 3 11 (Suppl.)
71. E. Perucca, and M. Bialer The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine Clinical Pharmacokinetics 31 1996 29 46
72. P.L. Pirie, D.M. Murray, and R.V. Luepker Gender differences in cigarette smoking and quitting in a cohort of young adults American Journal of Public Health 81 1991 324 327
73. C.S. Pomerleau, O.F. Pomerleau, R.J. Namenek, and A.M. Mehringer Short-term weight gain in abstaining women smokers Journal of Substance Abuse Treatment 18 2000 339 342
74. C.S. Pomerleau, A.N. Zucker, and A.J. Stewart Characterizing concerns about post-cessation weight gain: Results from a national survey of women smokers Nicotine and Tobacco Research 3 2001 51 60
75. M.A. Prendergast, D.T. Rogers, S. Barron, M.T. Bardo, and J.M. Littleton Ethanol and nicotine: A pharmacologic balancing act? Alcoholism, Clinical and Experimental Research 26 2002 1917 1918
76. J. Qian, and J.L. Noebels Topiramate alters excitatory synaptic transmission in mouse hippocampus Epilepsy Research 55 2003 225 233
77. D.S. Reddy Newer GABAergic agents for pharmacotherapy of infantile spasms Drugs of Today 38 2002 657 675
78. S.R. Resor Jr., L.D. Resor, D.M. Woodbury, and J.W. Kemp Acetazolamide R.H. Levy R.H. Mattson B.S. Meldrum Antiepileptic drugs 1995 Raven Press New York 969 985
79. W.E. Rosenfeld, S. Liao, L.D. Kramer, G. Anderson, M. Palmer, R.H. Levy, and R.K. Nayak Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy Epilepsia 38 1997 324 333
80. C.R. Russ, V.P. Fonseca, A.L. Peterson, L.R. Blackman, and A.S. Robbins Weight gain as a barrier to smoking cessation among military personnel American Journal of Health Promotion 16 2001 79 84
81. W.K. Schiffer, M.R. Gerasimov, D.A. Marsteller, J. Geiger, C. Barnett, D.L. Alexoff, and S.L. Dewey Topiramate selectively attenuates nicotine-induced increases in monoamine release Synapse 42 2001 196 198
82. M.J. Seaton, and E.S. Vesell Variables affecting nicotine metabolism Pharmacology and Therapeutics 60 1993 461 500
83. R.P. Shank, J.F. Gardocki, A.J. Streeter, and B.E. Maryanoff An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action Epilepsia 41 Suppl. 1 2000 S3 S9
84. S. Skradski, and H.S. White Topiramate blocks kainate-evoked cobalt influx into cultured neurons Epilepsia 41 Suppl. 1 2000 S45 S47
85. B.R. Smith, J.T. Horan, S. Gaskin, and Z. Amit Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm Psychopharmacology 142 1999 408 412
86. L.C. Sobell, M.B. Sobell, and T. Toneatto Recovery from alcohol problems without treatment N. Heather W.R. Miller J. Greeley Self-control and addictive behaviors 1991 Pergamon Press New York 198 242
87. S. Taverna, G. Sancini, M. Mantegazza, S. Franceschetti, and G. Avanzini Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate The Journal of Pharmacology and Experimental Therapeutics 288 1999 960 968
88. Y. Tizabi, R.L. Copeland J., V.A. Louis, and R.E. Taylor Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens Alcoholism, Clinical and Experimental Research 26 2002 394 399
89. R.G. Walton Smoking and alcoholism: A brief report The American Journal of Psychiatry 128 1972 1455 1456
90. C.K. Weekley III, R.C. Klesges, and G. Reylea Smoking as a weight-control strategy and its relationship to smoking status Addictive Behaviors 17 1992 259 271
91. F. Weiss, and L.J. Porrino Behavioral neurobiology of alcohol addiction: Recent advances and challenges The Journal of Neuroscience 22 2002 3332 3337
92. H.S. White Mechanism of action of newer anticonvulsants The Journal of Clinical Psychiatry 64 Suppl. 8 2003 5 8
93. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Research 28 1997 167 179
94. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism Epilepsia 41 Suppl. 1 2000 S17 S20
95. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychological Review 94 1987 469 492
96. X. Zhang, A.A. Velumian, O.T. Jones, and P.L. Carlen Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate Epilepsia 41 Suppl. 1 2000 S52 S60
97. R.S. Zimmerman, G.J. Warheit, P.M. Ulbrich, and J.B. Auth The relationship between alcohol use and attempts and success at smoking cessation Addictive Behaviors 15 1990 197 207
98. M.L. Zupanc Infantile spasms Expert Opinion on Pharmacotherapy 4 2003 2039 2048